141 related articles for article (PubMed ID: 16273004)
21. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.
Scagliotti GV; Selvaggi G
Clin Lung Cancer; 2008; 9 Suppl 3():S122-8. PubMed ID: 19419926
[TBL] [Abstract][Full Text] [Related]
22. Second-line treatment for advanced non-small cell lung cancer: how to design a clinical trial for a new agent?
Paesmans M; Berghmans T; Sculier JP
Lung Cancer; 2007 Feb; 55(2):135-6. PubMed ID: 17118490
[No Abstract] [Full Text] [Related]
23. Does maintenance pemetrexed maintain quality of life?
Stinchcombe TE; Cella D
Lancet Oncol; 2012 Mar; 13(3):224-5. PubMed ID: 22336220
[No Abstract] [Full Text] [Related]
24. Patients with advanced non-small-cell lung cancer and marginal performance status: walking the tight rope towards improved survival.
West HJ
J Clin Oncol; 2013 Aug; 31(23):2841-3. PubMed ID: 23835705
[No Abstract] [Full Text] [Related]
25. Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism?
Dogan M; Yalcin B; Utkan G; Urun Y; Ozal G
Lung Cancer; 2009 Dec; 66(3):399. PubMed ID: 19783320
[No Abstract] [Full Text] [Related]
26. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
[TBL] [Abstract][Full Text] [Related]
27. A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.
Grønberg BH; Bremnes RM; Aasebø U; Brunsvig P; Fløtten O; Amundsen T; von Plessen C; Wang M; Sundstrøm S;
Lung Cancer; 2009 Jan; 63(1):88-93. PubMed ID: 18538889
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen.
Velcheti V; Govindan R
Lung Cancer; 2007 Aug; 57(2):240-2. PubMed ID: 17400329
[TBL] [Abstract][Full Text] [Related]
29. [Multi-target tumor therapy].
Krankenpfl J; 2005; 43(1-3):38-9. PubMed ID: 15912831
[No Abstract] [Full Text] [Related]
30. Pemetrexed as a single agent in the therapy of advanced lung cancer.
Postmus PE; Bunn PA
Semin Oncol; 2002 Apr; 29(2 Suppl 5):17-22. PubMed ID: 12023788
[TBL] [Abstract][Full Text] [Related]
31. Interstitial pneumonitis after treatment with pemetrexed: a rare event?
Hochstrasser A; Benz G; Joerger M; Templeton A; Brutsche M; Früh M
Chemotherapy; 2012; 58(1):84-8. PubMed ID: 22377772
[TBL] [Abstract][Full Text] [Related]
32. [Management and maintenance of pemetrexed monotherapy regimen - initial experience of pretreated non-small cell lung cancer].
Takase M; Maruoka H; Ametani F; Takahashi M; Shibata K
Gan To Kagaku Ryoho; 2012 Apr; 39(4):563-5. PubMed ID: 22504678
[TBL] [Abstract][Full Text] [Related]
33. Reality check for pemetrexed and maintenance therapy in advanced non-small-cell lung cancer.
Murray N
J Clin Oncol; 2014 Feb; 32(5):482-3. PubMed ID: 24395844
[No Abstract] [Full Text] [Related]
34. Pemetrexed for treatment of advanced non-small cell lung cancer.
Fossella FV
Semin Oncol; 2004 Feb; 31(1 Suppl 1):100-5. PubMed ID: 14981587
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.
Ohe Y; Ichinose Y; Nakagawa K; Tamura T; Kubota K; Yamamoto N; Adachi S; Nambu Y; Fujimoto T; Nishiwaki Y; Saijo N; Fukuoka M
Clin Cancer Res; 2008 Jul; 14(13):4206-12. PubMed ID: 18594001
[TBL] [Abstract][Full Text] [Related]
36. Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Biron E; Pérol M; Guérin JC; Arpin D
Lung Cancer; 2009 Sep; 65(3):385-7. PubMed ID: 19346028
[TBL] [Abstract][Full Text] [Related]
37. Antimetabolites in the management of non-small cell lung cancer.
Budde LS; Hanna NH
Curr Treat Options Oncol; 2005 Jan; 6(1):83-93. PubMed ID: 15610718
[TBL] [Abstract][Full Text] [Related]
38. Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.
Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
Lung Cancer; 2009 Aug; 65(2):251-3. PubMed ID: 19346026
[TBL] [Abstract][Full Text] [Related]
39. Overview of phase II trials of MTA in solid tumors.
O'Dwyer PJ; Nelson K; Thornton DE
Semin Oncol; 1999 Apr; 26(2 Suppl 6):99-104. PubMed ID: 10598563
[TBL] [Abstract][Full Text] [Related]
40. New developments in chemotherapy for advanced non-small cell lung cancer.
Raez LE; Lilenbaum R
Curr Opin Oncol; 2006 Mar; 18(2):156-61. PubMed ID: 16462185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
